Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.

RPEP-140412025Wang, Shu-Hung; Serr, Isabelle; Digigow, Reinaldo; Metzler, Barbara; Surnov, Alexey; Gottwick, Cornelia; Alsamman, Muhammad; Krzikalla, Daria; Heine, Markus; Zahlten, Miriam; Widera, Agata; Mungalpara, Disha; Şeleci, Muharrem; Fanzutti, Marco; Marques Mesquita, Lígia Margarida; Vocaturo, Anna-Lisa; Herkel, Johannes; Carambia, Antonella; Schröter, Christian; Sarko, Dikran; Pohlner, Johannes; Daniel, Carolin; de Min, Cristina; Fleischer, Sabine

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.

Frontiers in immunology, 16, 1542380

View on PubMed ↗Publisher’s paper ↗

Citation

Wang, Shu-Hung; Serr, Isabelle; Digigow, Reinaldo; Metzler, Barbara; Surnov, Alexey; Gottwick, Cornelia; Alsamman, Muhammad; Krzikalla, Daria; Heine, Markus; Zahlten, Miriam; Widera, Agata; Mungalpara, Disha; Şeleci, Muharrem; Fanzutti, Marco; Marques Mesquita, Lígia Margarida; Vocaturo, Anna-Lisa; Herkel, Johannes; Carambia, Antonella; Schröter, Christian; Sarko, Dikran; Pohlner, Johannes; Daniel, Carolin; de Min, Cristina; Fleischer, Sabine. (2025). Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.. Frontiers in immunology, 16, 1542380. https://doi.org/10.3389/fimmu.2025.1542380